Skip to main content
OpenTrials

Clinical trial condition

Hereditary Sensory and Autonomic Neuropathies

Explore clinical trials studying Hereditary Sensory and Autonomic Neuropathies. Study availability and eligibility vary by location and protocol.

116 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Sensory and Autonomic Neuropathies trial results

Completed

The Vienna RAP Pilot Study

NCT01632605

Conditions
ADPKD, Abnormalities, Multiple, Ciliopathies, +21 more
Locations
  • Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna Vienna, State of Vienna, Austria
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

NCT03423628

Conditions
Astrocytoma, Behavior, Brain Diseases, +31 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

NCT06433219

Conditions
Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California San Francisco - UCSF Medical Center San Francisco, California, United States
  • Centricity Research Cancer Center - DBA CRRI John B. Amos Cancer Center Research Columbus, Georgia, United States
  • University of Chicago Comprehensive Cancer Center at Silver Cross - Carolyn J. Czerkies Pavilion Chicago, Illinois, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

NCT05882734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • UCLA Hematology and Oncology - Santa Monica Santa Monica, California, United States
  • UPMC Cancer Center Pittsburgh, Pennsylvania, United States
  • Tennessee Cancer Specialists - Biomedical Research Knoxville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions
Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Irvine Health Orange, California, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

NCT05159700

Conditions
Advanced Solid Malignancies, Advanced Solid Tumor, Congenital Abnormalities, +10 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • NEXT Oncology Austin, Texas, United States
View Trial Details

Related conditions